Alloy Women's Health raises $16M in Series A to expand menopause telehealth platform
New York-based Alloy Women's Health has secured $16 million in a Series A funding round led by Kairos HQ, with participation from PACE Healthcare Capital, Emmeline Ventures, and Amboy Street Ventures. The investment will support the growth of Alloy’s telehealth platform that provides specialized menopause care for women.
Founded by Anne Fulenwider and Monica Molenaar, Alloy Women’s Health offers access to doctors trained in menopause management, FDA-approved hormonal prescription treatments, and personalized educational content. The platform addresses a significant gap in women’s health by delivering tailored care during a critical life stage.
Deal Details
Amount: $16 million
Round: Series A
Investors: Kairos HQ, PACE Healthcare Capital, Emmeline Ventures, Amboy Street Ventures
Location: New York, USA
About Alloy Women's Health
Alloy Women's Health is a telehealth company dedicated to improving menopause care through digital health solutions. The platform connects users with specially trained physicians who provide personalized care plans, including FDA-approved hormonal therapies. Alloy also offers customized content to educate and support women navigating menopause, a stage often underserved by traditional healthcare. Since its founding by female entrepreneurs Anne Fulenwider and Monica Molenaar, the company has gained traction in the growing femtech market by addressing a critical need for accessible, specialized care.
What This Means
This funding round underscores the increasing investor interest in femtech and women’s health startups addressing midlife health challenges. With menopause care historically under-resourced, Alloy’s platform represents a timely innovation to improve health outcomes and patient experience. The $16 million Series A will enable Alloy to scale its telehealth services, expand its medical team, and enhance its digital offerings to meet rising demand in the U.S. market.
Sources: